Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme

Bibliographic details

Authors

V. Russo, C. C. Wang, M. Unverdorben, T. Yamashita, Ladislav Pecen, A. Borrow, C. Chen, P. Kirchhof, R. De Caterina

Publication year

2022

Publication type

Abstrakt

Periodical

European Heart Journal

Bibliographic citation

RUSSO, V., WANG, C. C., UNVERDORBEN, M., YAMASHITA, T., PECEN, Ladislav, BORROW, A., CHEN, C., KIRCHHOF, P., DE CATERINA, R. Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme. European Heart Journal. 2022, 43(Suppl. 2), 2701-2701. ISSN 0195-668X. E-ISSN 1522-9645
Dostupné z: doi:10.1093/eurheartj/ehac544.2701

DOI

10.1093/eurheartj/ehac544.2701

ID

572206